| 发明名称 |
Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 摘要 |
Use of sodium chloride for preparing an agent intended to reduce or eliminate the gastrointestinal side effects induced by the administration of camptothecin derivatives, characterized in that the sodium chloride solution is administered orally.
|
| 申请公布号 |
US6476043(B1) |
申请公布日期 |
2002.11.05 |
| 申请号 |
US20010762092 |
申请日期 |
2001.03.21 |
| 申请人 |
AVENTIS PHARMA S.A. |
发明人 |
TOUTAIN HERVE;GUFFROY MAGALI |
| 分类号 |
A61K31/4375;A61K9/00;A61K31/4745;A61K33/00;A61K33/14;A61K45/06;A61K47/02;A61K47/12;A61K47/26;A61P1/00;A61P35/00;A61P39/00;A61P39/02;(IPC1-7):A01N43/42 |
主分类号 |
A61K31/4375 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
